Investigating netrin1-mediated commissural axon guidance in the developing spinal cord

研究 netrin1 介导的连合轴突对发育中脊髓的引导

基本信息

  • 批准号:
    10396437
  • 负责人:
  • 金额:
    $ 3.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-01 至 2022-09-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract The function of the nervous system is dependent on the correct formation of neural circuits during development. Circuits are generated when growth cones at the tips of axons use molecular cues in the environment to guide axon extension. Netrin1 is an axon guidance cue first thought to acts as a long-range, diffusible, chemoattractant that emanates from the floor plate (FP). However, recent work by the Butler lab and other groups, has suggested this model is incorrect. In the mouse spinal cord, netrin1 is expressed by both FP cells and neural progenitor cells (NPCs) in the ventricular zone (VZ). In the absence of either netrin1 or its receptor Dcc, axons innervate the VZ and commissural axons either stall or defasciculate. These phenotypes are only observed when netrin1 is removed from NPCs and not the FP cells, suggesting NPC-derived netrin1 is responsible for guiding axon extension. Our studies suggest that NPC-derived netrin1 is deposited on the pial surface (margin) of the spinal cord, where it acts as an adhesive substrate that promotes commissural axon outgrowth. My objective is to define the mechanisms that allow netrin1 to be transported to the pial surface of the spinal cord. In the visual system, netrin1 can be cleaved into fragments, isoforms, with unique spatial and biological properties. This led me to believe that cleavage of netrin1 facilitates its transport to the pial surface. My preliminary data suggests that netrin1 isoforms exist in the spinal cord, and that netrin1 is differentially cleaved to permit its localization to different regions of the spinal cord. Furthermore, my data suggests that netrin1 transport is mediated by the motor protein Kif1a. In Aim 1, I will track the path of netrin1 from the VZ onto the pial surface using high resolution microscopy and characterize the sequence of netrin1 isoforms, using mass spectrometry. In Aim 2, I will use SiRNA knockdown and gain-of-function studies to investigate if KiF1a is necessary for the transport of netrin1. Investigating these mechanisms is critical to 1) gaining a better understanding of the basis of neurodevelopmental disorders and 2) the repair and regeneration of damaged circuits.
项目摘要/摘要 神经系统的功能依赖于神经回路的正确形成 发展。当轴突顶端的生长锥体使用分子线索时,就会产生回路 引导轴突延伸的环境。Netrin1是一种轴突引导信号,最初被认为是起远程作用的, 从底板(FP)发出的可扩散的化学吸引剂。然而,巴特勒实验室最近的工作和 其他团体表示,这种模式是不正确的。在小鼠脊髓中,Netrin1由FP和Fp共同表达 脑室带(VZ)内的细胞和神经前体细胞(NPC)。在缺少netrin1或其 DCC受体,轴突支配VZ,连合轴突停滞或脱束。这些表型 只有当从NPC而不是FP细胞中去除netrin1时才能观察到,这表明鼻咽癌来源的netrin1 负责引导轴突延伸。我们的研究表明,鼻咽癌来源的netrin1沉积在 脊髓的硬膜表面(边缘),在那里它起促进连合的粘附性基质的作用 轴突生长。我的目标是定义允许netrin1传输到pial的机制。 脊髓的表面。在视觉系统中,netrin1可以被切割成片段、异构体、具有唯一性 空间和生物特性。这让我相信,netrin1的裂解有助于将其运输到 Pial表面。我的初步数据表明,netrin1亚型存在于脊髓中,而netrin1是 不同的裂解以允许其定位于脊髓的不同区域。此外,我的数据 提示netrin1的转运是由运动蛋白Kif1a介导的。在目标1中,我将跟踪netrin1的路径 使用高分辨率显微镜从VZ到软膜表面,并对netrin1的序列进行分析 异构体,使用质谱学。在目标2中,我将使用siRNA敲除和功能获得研究来 调查是否需要KiF1a来运输netrin1。研究这些机制对1)至关重要 更好地了解神经发育障碍的基础和2)修复和 损坏电路的再生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sandy Alvarez其他文献

Sandy Alvarez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 3.4万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 3.4万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 3.4万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.4万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 3.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了